1. Office of Biologics Research and Review, USFDA (1987) Points to consider in the manufacture and testing of monoclonal antibody products for human use
2. Office of Biologies Research and Review. USFDA (1987) Points to consider in the characterization of cell lines used to produce biologicals.
3. Commission of the European Community (1991) Validation of virus removal and inactivation procedure
4. Pharmaceutical Affairs Bureau. Ministry of health and welfare. Japan (1988) Yakushm l gou. No 10
5. Prince, A.M., Stephan, W. and Brotman, B. (1983) β-propiolactone/ultraviolet irradiation a review of its effectiveness for inactivation of viruses in blood derivatives. Rev. Infect. Dis
1. 92–107